Digital Intervention Increasing Sleep Duration Among People With Type 2 Diabetes: Pilot Randomized Controlled Trial
Primary result · HbA1c changeResult — go to the resultBetween-arm difference in change −0.11 %Authors' conclusion
In this randomized trial, an average sleep extension of approximately 30 minutes over 12 weeks did not result in a significant improvement in HbA1c among short-sleeping adults with type 2 diabetes. Further studies with larger sample sizes and greater sleep extension are warranted.
Study context
- Population
- Short-sleeping (≤6 hours) people with T2D in Japan
- Participants
- 70 participants
- Comparison
- Personalized digital bedtime advancement support vs control
- Primary endpoint
- Between-arm difference in HbA1c change
- Follow-up
- 12 weeks
Methodological detailspilot, single-blind, two-arm
- Pilot
- Single-blind
- Two-arm
Primary result
HbA1c change
Between-arm difference in change
−0.11 %
P = 0.51
As reported in the abstract
Further findings
Baseline sleep duration
Baseline HbA1c
| Outcome | Between-arm difference in change (minutes) | P value |
|---|---|---|
| Sleep duration change · 12 weeksSleep duration improved with intervention | 32.8 | P = 0.0042 |
Association of sleep duration increase with hemoglobin A1c (HbA1c) reduction
- Increases in sleep duration not significantly associated with HbA1c reduction
- P = 0.69
Original publication
Digital Intervention Increasing Sleep Duration Among People With Type 2 Diabetes: Pilot Randomized Controlled Trial. J Diabetes Sci Technol. Published 6 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →